487.5500 -6.25 (-1.27%)
NSE Oct 15, 2026 15:31 PM
Volume: 261.6K
 

487.55
-1.27%
ICICI Securities Limited
Thyrocare’s Q2FY24 performance was in line with our expectations. Its revenue grew 9.7% YoY while the franchisee business grew faster at 20%. It reported an improvement in gross margins (+100bps YoY) due to a decline in the lowmargin Partnership business.
Thyrocare Technologies Ltd. is trading below its 30 day SMA of 545.0
More from Thyrocare Technologies Ltd.
Recommended